Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersonal Group Regulatory News (PGH)

Share Price Information for Personal Group (PGH)

Share Price is delayed by 15 minutes
Get Live Data
395.00    0.00 (0.00%)
Bid:
390.00
Ask:
400.00
Spread: 10.00 (2.564%)
Market Cap: £124.45m
PGH Live PriceLast checked at - London Stock Exchange

Intraday Personal Group Share Chart

PDMR purchase of shares

28 Jan 2019 16:19

RNS Number : 3169O
Personal Group Holdings PLC
28 January 2019
 

 

 

Personal Group Holdings plc

 

("the Company")

 

 

PDMR purchase of shares

 

Personal Group Holdings Plc operates an Inland Revenue approved Employee Share Ownership Plan which allows employees and directors the opportunity to purchase ordinary shares of 5p each in the Company ("Shares") currently held by Personal Group Trustees Limited.

The thirty third allocation period ended on 31 December 2018 and the following PDMRs have acquired Shares on 1 January 2019 as follows:

 

Director

Price paid per Share

Shares purchased

Total number of ordinary shares held following transaction

% of Company's issued share capital

Mr M Scanlon

446.00p

251

3,016

0.010

Mr K Rooney

446.00p

254

2,430

0.008

Mr M Dugdale

446.00p

264

40,107*

0.130

Ms D Rees-Frost

446.00p

215

783

0.003

Mr A Doody

446.00p

20

852

0.003

Mr A Lothian

446.00p

13

38,077**

0.123

 

* This figure includes Mr Dugdale's wife's holding of 18,069 ordinary shares.

** This figure includes Mr Lothian's wife's holding of 17,570 ordinary shares.

Under the Rules of the plan, the share price at which the shares are purchased is the lower of the mid-market value at the start and end of the relevant accumulation period.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

1. Mark Scanlon

2. Ken Rooney

3. Mike Dugdale

4. Deborah Rees-Frost

5. Ashley Doody

6. Andrew Lothian

2

 

Reason for the notification

 

a)

 

Position/status

 

 

1. Mark Scanlon - Director/ PDMR

2. Ken Rooney - Director/ PDMR

3. Mike Dugdale - Director/ PDMR

4. Deborah Rees-Frost - Director / PDMR

5. Ashley Doody - PDMR

6. Andrew Lothian - Director / PDMR

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Personal Group Holdings Plc

b)

 

LEI

 

 

213800TN8BH2YYWAH345

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 5p each

 

 

ISIN: GB0002760279

 

 

 

b)

 

Nature of the transaction

 

 

Purchase of shares pursuant to All Employee Share Ownership Plan

c)

 

Price(s) and volume(s)

 

 

Director/PDMR

Price(s)

 

Volume(s)

1. M Scanlon

2. K Rooney

3. M Dugdale

4. D Rees-Frost

5. A Doody

6. A Lothian

446.00p

446.00p

446.00p

446.00p

446.00p

446.00p

251

254

264

215

20

13

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

 

1,017 shares

 

 

£4.46 per share

 

 

e)

 

Date of the transaction

 

 

1 January 2019

f)

 

Place of the transaction

 

 

Outside a trading venue

 

 

-ENDS-

 

For more information please contact:

Personal Group Holdings Plc

 

Mike Dugdale - Chief Financial Officer

+44 (0)1908 605 000

Philip Dennis -

+44 (0)7947 868 206

 

Cenkos Securities Plc

 

Max Hartley / Stephen Keys (Nomad)

+44 (0)20 7397 8900

Russell Kerr (Sales)

 

 

Media enquiries:

Hudson Sandler

 

Nick Lyon / Sophie Lister / Lucy Wollam

+44 (0)20 7796 4133

Personalgroup@hudsonsandler.com

 

 

  

Notes to Editors:

 

Personal Group Holdings Plc (AIM: PGH) is a technology enabled employee services business, working with employers to drive productivity though better employee engagement and a more motivated workforce. With over 30 years' experience, the Company provides employee benefits and services to over 2 million employees across the UK.

Personal Group's offer comprises 8,000 in-house and third party products and services, from c.60 supply lines. In-house services include employee insurance products (hospital, convalescence plans and death benefit) and the provision of home technology via salary sacrifice (iPads, computers, laptops, smart phones and smart TVs). Third party services include retail discounts, e-payslips, employee assistance programmes, wellbeing programmes and salary sacrifice cars and bikes.

The offer is provided via the Company's proprietary technology platform, Hapi. The platform is intuitive, designed primarily for app deployment and also accessible via web and tablet, driving better engagement, communication and value recognition. Hapi is flexible and can quickly integrate additional services, such as existing employee services and partner platforms. Hapi is a SaaS product.

Through technology and select acquisitions, the Company has grown its addressable market from 6m to over 27m UK employees; including 15.6m SME employees targeted via its partnership with Sage, the UK's largest software company.

Personal Group's innovative approach to using technology to deliver its programmes, combined with its face-to-face method of communicating with employees, makes its offer compelling to blue chip clients across the UK as a way of attracting, retaining and motivating employees.

Personal Group has a strong client base across a range of sectors including passenger transport, healthcare, logistics and food manufacturing. Clients include: Stagecoach, Four Seasons Health Care, Priory Group, Spire Healthcare, Bibby, 2 Sisters Food Group and Young's Seafood.

For further information, please see www.personalgroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHMMGZMVRKGLZM
Date   Source Headline
28th May 20263:51 pmRNSGrant of LTIP
12th May 20263:30 pmRNSDirector/PDMR Shareholding
7th May 20264:02 pmRNSResult of AGM
7th May 20267:00 amRNSAGM Statement
23rd Apr 20267:00 amRNSExercise of Options, PDMR and Total Voting Rights
13th Apr 20267:00 amRNSAGM Notification
1st Apr 20262:00 pmRNSHolding(s) in Company
24th Mar 20267:02 amRNSPreliminary Results and Final Dividend
23rd Mar 20267:00 amRNS-RNew Insurance Partnership
12th Mar 20267:00 amRNSNotice of Analyst and Investor Presentations
5th Feb 202612:00 pmRNSHolding(s) in Company
28th Jan 202611:00 amRNSHolding(s) in Company
28th Jan 20267:00 amRNSTrading Update & Notice of Full Year Results
21st Jan 20262:45 pmRNSHolding(s) in Company
21st Jan 202611:00 amRNSHolding(s) in Company
6th Jan 20267:00 amRNSDirector/PDMR Shareholding
11th Dec 202512:00 pmRNSHolding(s) in Company
2nd Dec 20257:00 amRNSCFO Succession
24th Nov 20257:00 amRNSNotification of major holdings
7th Nov 20255:41 pmRNSDirector/PDMR Shareholding
30th Sep 20255:00 pmRNSHolding(s) in Company
16th Sep 20257:00 amRNSInterim Results
27th Aug 20257:00 amRNSNotice of Results and Presentations
23rd Jul 20257:00 amRNSH1 2025 Trading Update
18th Jul 202510:18 amRNSReplacement: PDMR Share Dealing
14th Jul 20254:09 pmRNSPDMR Share Dealing
27th May 20257:00 amRNS-RPGH Presenting at the Mello 2025 Conference
19th May 20255:13 pmRNSDirector/PDMR Shareholding
15th May 20253:58 pmRNSDirector/PDMR Dealings
8th May 20255:10 pmRNSResult of AGM
8th May 20257:00 amRNSAGM Trading Statement
29th Apr 202511:51 amRNSExercise of Options, PDMR Dealing and TVR
28th Apr 20255:03 pmRNSHolding(s) in Company
9th Apr 20257:00 amRNSGrant of LTIP
8th Apr 20257:00 amRNSAGM Notification
7th Apr 20254:23 pmRNSDirector/PDMR Dealings
1st Apr 20257:00 amRNSDirectorate Change
27th Mar 20257:00 amRNSPartnership Renewal & Expansion with Sage Group
25th Mar 20257:00 amRNSPreliminary Results and Final Dividend
14th Mar 20257:00 amRNSNotice of Analyst and Investor Presentation
24th Feb 20256:00 pmRNSHolding(s) in Company
28th Jan 20257:00 amRNSTrading Update & Notice of Full Year Results
3rd Jan 20257:00 amRNSPDMR Share Dealing
13th Nov 20243:45 pmRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSDirector/PDMR Shareholding
3rd Oct 20244:19 pmRNSNotification of major holdings
3rd Oct 20244:16 pmRNSNotification of major holdings
30th Sep 20244:25 pmRNSNotification of major holdings
24th Sep 20247:00 amRNSInterim Results
16th Sep 20247:00 amRNSNotice of Results & Presentations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.